title: Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.
abstract: Many existing and emerging cancer therapies have a significant effect on the cardiovascular health of patients with cancer and cancer survivors. This paper examines current aspects of interdisciplinary cardio-oncology clinical care delivery and education in the United States and outlines how these data provide a platform for future development of the field. We present the results of the nationwide survey on cardio-oncology services, practices, and opinions, conducted among chiefs of cardiology and program directors, which demonstrate ranges of clinical activities and identify significant interest for increased educational opportunities and expert training of cardiovascular physicians in this field. The survey respondents recognized clinical relevance but emphasized lack of national guidelines, lack of funds, and limited awareness and infrastructure as the main challenges for development and growth of cardio-oncology. We discuss potential solutions to unmet needs through interdisciplinary collaboration and the active roles of professional societies and other stakeholders.
authors.affiliation: MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC. Electronic address: Ana.Barac@medstar.net.
authors.forename: Ana
authors.initials: A
authors.lastname: Barac
authors.affiliation: Northwestern Memorial Hospital, Chicago, Illinois.
authors.forename: Gillian
authors.initials: G
authors.lastname: Murtagh
authors.affiliation: Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Carver
authors.affiliation: Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
authors.forename: Ming Hui
authors.initials: MH
authors.lastname: Chen
authors.affiliation: National Jewish Health, Denver, Colorado.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Freeman
authors.affiliation: Mayo Clinic and College of Medicine, Rochester, Minnesota.
authors.forename: Joerg
authors.initials: J
authors.lastname: Herrmann
authors.affiliation: MD Anderson Cancer Center, Houston, Texas.
authors.forename: Cezar
authors.initials: C
authors.lastname: Iliescu
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Bonnie
authors.initials: B
authors.lastname: Ky
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
authors.forename: Erica L
authors.initials: EL
authors.lastname: Mayer
authors.affiliation: Rush University Medical Center, Chicago, Illinois.
authors.forename: Tochi M
authors.initials: TM
authors.lastname: Okwuosa
authors.affiliation: Baylor College of Medicine, Houston, Texas.
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Plana
authors.affiliation: The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Ryan
authors.affiliation: American College of Cardiology, Washington, DC.
authors.forename: Anne K
authors.initials: AK
authors.lastname: Rzeszut
authors.affiliation: Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Douglas
mesh_terms: D002309:Cardiology / Q000639:trends*; D002318:Cardiovascular Diseases / Q000150:complications* / Q000628:therapy*; D003625:Data Collection; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D017741:Survivors
keywords: cancer survivorship; cardio-oncology; cardiovascular risk prevention; cardiovascular toxicity